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Abstract
An abdominal aortic aneurysm is an irreversible dilatation of the abdominal aorta. The majority of abdominal
aortic aneurysms are asymptomatic and identified incidentally while investigating a separate pathology. Others are
detected by national screening programmes and some present due to a growth or rupture. Symptomatic or
ruptured aneurysms require urgent or emergency repair in patients fit for surgery. Perioperative practitioners
should therefore be aware of how patients with abdominal aortic aneurysms present and are investigated, so that they
can implement timely management. Guidelines have been recently updated to reflect this. This literature
review discusses these recommendations and explores the evidence upon which they are based. The aim of this
article is to highlight the important preoperative principles that need to be considered in cases of abdominal aortic
aneurysm.
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Introduction
An abdominal aortic aneurysm (AAA) is an irreversible
dilatation of the abdominal aorta to a diameter greater
than 3.0cm or 1.5 times its normal anteroposterior
diameter (NICE 2020). In 2019, Public Health England
(PHE) reported that approximately 0.97% of men
screened had an AAA, although this value varied from
0.66% to 1.77% depending on geographical location
(PHE 2019). This figure represents a continued yearly
decline in AAA incidence in England and is the first time
it has fallen below 1% (PHE 2019). Similarly, the number
of deaths due to AAA rupture has been decreasing over
time (Anjum et al 2012). These trends are largely
attributable to an overall reduction in the rate of
smoking and increases in elective AAA repair in those
aged 75 years and over (Anjum et al 2012).
While elective AAA repair is generally associated with
low mortality rates, ruptured AAAs (rAAAs) are
still associated with an average in-hospital mortality of
35.4% after surgery (National Vascular Registry 2019).
In fact, a large-scale systematic review reported that
the mortality rate from AAAs reaches a staggering 81%
when pre-hospital deaths are included (Reimerink et al
2013).
AAAs also represent a significant economic burden on
healthcare systems. In the UK, the estimated hospital
cost for the surgical repair of an AAA has been reported
as £12,806 for elective cases, and £19,984 for
emergency open repair (Thompson et al 2013).
Moreover, in 2019, patients admitted with a rAAA in the
UK spent a median of eight days in the hospital (NHS
2019). Significant costs are also incurred by national
screening programmes, although AAA screening in
England has proven highly cost-effective in terms of
quality-adjusted life-years gained (Glover et al 2014).
Due to the catastrophic nature of AAA rupture, the
National Institute for Health and Care Excellence (NICE),
the European Society for Vascular Surgery (ESVS) and
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the Society for Vascular Surgery (SVS) have recently
published comprehensive guidelines on the diagnosis,
surveillance and management of AAAs (Chaikof et al
2018, NICE 2020, Wanhainen et al 2019). This review
explores these recommendations, highlighting the key
preoperative factors that need to be considered to
optimise the care that these patients receive.
Risk factors
AAA development
Age, gender, ethnicity and prior cardiovascular disease
(CVD) are large non-modifiable risk factors for the
development of AAAs. After the age of 65 years, the risk
of developing an AAA increases by 40% every five years
(Vardulaki et al 2000). In addition, a screening study of
2.3 million individuals identified a 6-fold increase in the
age-adjusted prevalence of AAAs in men, compared to
women (Carter et al 2020). White-British individuals are
also at a greater risk of AAA development than black/
black-British and Asian/Asian-British individuals
(Benson et al 2016), as are those with prior history of
CVD. It has recently been shown that, in a cohort with no
known CVD, the incidence of AAA is as low as 0.6%
(Carter et al 2020). Similarly, patients with other
conditions such as connective tissue disorders are at an
increased risk of AAA development (Rahimi 2019).
There are various modifiable risk factors that physicians
need to consider and communicate to their patients.
These include high systolic blood pressure, BMI, serum
triglycerides and low-density lipoprotein levels (Summers
et al 2020). Perhaps the largest modifiable-risk factor is
current smoking. This affects females more than males,
with a large cross-sectional study reporting a 15-fold
increase in the risk of AAA amongst women compared to
a 7-fold increase amongst men (Carter et al 2020). The
effects of smoking are also dose-dependent, with a
relative risk of 1.78 per every 10 pack-years (Aune et al
2018). Conversely, it has been shown that a linear
inverse association exists between the duration of
smoking cessation and the risk of AAAs. After 25 years
of cessation, this risk approaches that of never-smokers
(Aune et al 2018). Other protective factors against AAA
development include a healthy diet and exercise more
than once a week (Kent et al 2010).
AAA growth and rupture
AAAs grow insidiously in the absence of symptoms. Each
0.5 cm increase in AAA diameter increases growth rates
by 0.5mm/year and doubles rupture rates (Thompson et
al 2013). In smokers, the growth rate is increased by a
further 0.35mm/year and the rupture rate doubles
(Thompson et al 2013). The rate of rupture also
increases with blood pressure and is almost 4-fold
higher in women than men, despite AAAs being more
common in males (Thompson et al 2013). Interestingly,
diabetes mellitus (DM) may protect against both the
expansion and rupture of AAAs, as well as re-growth and
the need for re-intervention after endovascular AAA
repair (Raffort et al 2018). However, reports also
suggest that DM increases intraoperative mortality and
the rate of postoperative complications like myocardial
infarction, infection and pancreatitis (Raffort et al 2018).
Screening
A number of countries, including the United Kingdom
(UK), have dedicated AAA screening programmes. In the
UK, every male is invited for screening within the year of
their 65th birthday (PHE 2019). Self-referral to the
screening programme is accepted for men over 65 who
have not been previously screened, and should be
encouraged if any of the following risk factors are
present: COPD, coronary, cerebrovascular or peripheral
arterial disease, hypertension, hyperlipidaemia, a
current or past smoking history and a family history of
AAA (NICE 2020, PHE 2019).
Screening involves a single supine abdominal
ultrasound scan. The aorta is assessed from the
proximal extent of the suprarenal abdominal aorta to the
level of the aortic bifurcation and two measurements are
taken, one with the probe in the longitudinal plane and
the other in the transverse plane (Figure 1; PHE 2016).
Specifically, an inner-to-inner maximum anterior-
posterior aortic diameter should be taken (NICE 2020).
If the abdominal aortic diameter is <3.0cm, it is classed
as normal and no further follow-up is required (NHS
2017). An aortic diameter of 3.0–4.4cm is classed as a
small AAA, while medium AAAs are between 4.5 and
5.4cm and large AAAs measure 5.5cm (NHS 2017).
These results are found in approximately 1%, 0.5% and
0.1% of patients, respectively (NHS 2017). Small-to-
medium asymptomatic aneurysms are managed
conservatively with periodic ultrasound surveillance.
This occurs yearly for small AAAs and three monthly for
medium AAAs (PHE 2019). Large aneurysms are
referred directly to vascular services for diagnosis and
treatment (PHE 2019). The indications for surgical repair
are discussed later in this article.
Upon diagnosis, patients should be given information
regarding AAAs, the risks of growth and rupture, and the
treatment options available (NICE 2020). As it may be
an emotionally challenging diagnosis to receive, patients
should be reassured that most AAAs are unproblematic
(NICE 2020). In fact, a UK study of over 5000 men with
small or medium AAAs found that mental quality of life
was transiently reduced in the year following AAA
diagnosis (Bath et al 2018). It is therefore beneficial to
offer patients advice and psychological support, for
example by referral to a Vascular Nurse Specialist
(Rankin 2016).
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Between April 2018 and March 2019, 18.7% of eligible
men did not undergo screening in the UK (PHE 2019).
Reasons for this may include accidental missed
appointments, logistical errors, an inability to travel to
the screening site and preference. This finding was
echoed by a study of national cohorts for two
consecutive years, covering 593,032 invitees for
screening. Men living in the most deprived decile were
significantly more likely to decline screening or not
attend their appointment, despite AAAs being twice as
common in this population (Jacomelli et al 2017).
Screening for AAA has been shown to significantly
reduce mortality rates in 65 to 74-year-old men
(Thompson et al 2012). Currently, the national screening
programme in the UK does not include females, due to
evidence that AAA screening is unlikely to be cost-
effective in women (Sweeting et al 2018). This is echoed
in the ESVS guidelines, in which cost-effectiveness and
harm-benefit analyses are performed (Wanhainen et al
2019). It is, however, acknowledged by NICE and the
literature that AAAs are more likely to rupture in women
(NICE 2020, Sweeting et al 2012). In fact, women
account for one-third of all deaths from a rAAA (Office for
National Statistics 2018), despite the prevalence of AAA
being approximately six times lower in women (NICE
2020). A recent study in the UK demonstrated that
women have a higher in-hospital mortality rate than men
after elective AAA repair, irrespective of repair method
(Sidloff et al 2017). Therefore, clinicians should retain a
high index of suspicion if female patients present with
signs and symptoms of an AAA.
Presentation
The majority of AAAs are asymptomatic and are detected
incidentally while investigating a different pathology
(Aggarwal et al 2011). In a large study of 79,121
abdominal ultrasound, computed tomography (CT) and
magnetic resonance imaging (MRI) scans, an incidental
AAA was found in 1% of patients (Van Walraven et al
2010). When symptomatic, an unruptured AAA may
present with a pulsating pain or sensation in the
stomach or groin (Petriceks et al 2018) and/or a chronic
lower back pain from vertebral column erosion
(Yildizgoren et al 2016).
As many as 50% of patients with an AAA will have a rAAA
as their primary presentation (Jeanmonod et al 2020).
This may occur spontaneously or as a result of trauma
(Chiriano et al 2010). The classic triad of presentation
for a rAAA consists of hypotension, flank or back pain
and a pulsatile abdominal mass, typically in a patient
over the age of 50 (Yien et al 2008). However, in as
many as 50% of patients, this triad may be incomplete
(Yien et al 2008). A rAAA should therefore be suspected
in any patient >50 years with abdominal pain (RCEM
2019). Other common presentations include shortness
of breath, tachycardia and flank or periumbilical
ecchymosis (Grey Turner or Cullen signs, respectively)
(NHS 2017, Su et al 2020). It is important that doctors
are aware of these features to aid their clinical decision-
making, as in a six-year retrospective cohort study, 33%
of patients with a rAAA were misdiagnosed upon primary
assessment, with a trend to more frequent misdiagnosis
in women (Smidfelt et al 2017). The most common rAAA
misdiagnosis is renal colic (Marston et al 1992).
Examination
Examination of a suspected AAA should involve using
two hands to deeply palpate above and to the left of the
umbilicus. Usually, a pulsatile aorta can be felt; however,
in cases of AAA, an expansile mass may also be
appreciated (Aggarwal et al 2011, Smith-Burgess 2017).
Patients with pain and tenderness on abdominal
palpation have an increased risk of AAA rupture
(Aggarwal et al 2011), but palpation itself is not a
precipitating event for rupture (Chaikof et al 2018). It
should therefore not deter clinicians from performing a
Figure 1 Appearance on ultrasound. (I) Transverse view of an
AAA. (II) Longitudinal view. In both, a central lumen (a), an area
of stable thrombus (b), and areas of dissection or haemorrhage
within the thrombus (c) can be seen. Reproduced with permis-
sion from Goldstein and Wells (2019)
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thorough examination. It is also important to auscultate
the aorta to detect an aortic bruit, which can be
suggestive of arterial atherosclerotic disease (Aggarwal
et al 2011). In addition, the femoral and popliteal
arteries should be assessed (Chaikof et al 2018). As
many as 14% of men with an AAA have been shown to
have a coexisting femoral or popliteal aneurysm (Diwan
et al 2000).
Although physical examination can be very useful, it only
has a moderate sensitivity for detecting AAAs (Aggarwal
et al 2011). Moreover, its accuracy is significantly
reduced in smaller aneurysms and in patients with a
larger BMI (Venkatasubramaniam et al 2004). It is,
therefore, important to order the following
investigations.
Investigations
Abdominal ultrasonography is the investigation of choice
for suspected AAAs, as well as routine screening (NICE
2020). If this scan detects an aneurysm that measures
3.0–5.4 cm, the patient must be seen at a regional
vascular service within 12 weeks (NICE 2020). If the AAA
is 5.5 cm, the patient must instead be seen within two
weeks (NICE 2020). In the emergency setting, bedside
ultrasound is also a quick, convenient and reliable
imaging modality, with a sensitivity of 96.3% and
specificity of 100% for rAAAs (Dent et al 2007). Basic
observations and an ECG should also be taken at the
bedside, to assess for cardiovascular collapse and
peri-arrest rhythms, respectively.
Both unruptured and rAAAs must also be investigated
using blood tests. These include a full blood count, urea
and electrolytes, liver function tests and blood group
(Rahimi 2019). Furthermore, it is important that prior to
surgical repair (elective or emergency), the patient is
crossmatched as massive blood transfusion is required
in 71% of rAAAs (Montan et al 2016).
In addition, NICE recommend that patients undergo thin-
slice contrast-enhanced arterial-phase CT angiography
(NICE 2020). This allows for anatomical mapping of the
AAA in relation to the renal and iliac arteries, planning
the appropriate surgical intervention (Boyle et al 2005)
and predicting prognosis, for example patients with
shorter aneurysm necks have poorer outcomes
(IMPROVE 2015). In cases of rAAAs, it can also assess if
the rupture is impending or complete, and the extent of
aortic wall involvement (Vu et al 2014). However, it is
inappropriate to CT unstable, hypotensive patients who
need immediate transfer to a vascular surgery centre
(NICE 2020). There are no investigations classed as
essential for transfer, in order to avoid delay in surgical
repair (RCEM 2019).
Decision for surgical repair
For unruptured AAAs, NICE recommend that clinicians
consider surgical repair if patients are either
symptomatic, asymptomatic with an AAA >4 cm that has
grown >1 cm in one year, or asymptomatic with an AAA
5.5cm (NICE 2020). The ESVS guidelines also
recommend surgical repair for male patients with an
AAA diameter 5.5 cm, though the threshold is lowered
to 5.0 cm for female patients (Wanhainen et al 2019).
This is in line with the SVS guidelines, which recommend
that for women, surgical repair can be performed
between 5 and 5.4cm (Chaikof et al 2018).
The decision for surgical repair must also involve an
evaluation of the patient's age, life expectancy, fitness
for surgery and medical comorbidities (NICE 2020). Non-
invasive stress testing is recommended for patients with
cardiovascular risk factors (Chaikof et al 2018, NICE
2020). An ECG should be performed for all patients
within 30-days of a planned intervention and should an
active condition be found, referral for cardiac work-up
and optimisation is recommended (Chaikof et al 2018,
Wanhainen et al 2019). Furthermore, preoperative
pulmonary function testing and optimisation, including
arterial blood gas analysis, are recommended for
patients with risk factors for pulmonary complications or
a recent decline in respiratory function (Chaikof et al
2018, Wanhainen et al 2019). Abnormal results may
require the administration of bronchodilators for at least
two weeks before repair (Chaikof et al 2018).
Assessment of renal function should also be conducted
for all patients preoperatively. Patients with severe
impairment should be referred to a renal physician and
will need adequate hydration and monitoring
perioperatively (Wanhainen et al 2019). NICE does not
advocate the use of risk assessment tools to determine
suitability for surgery (NICE 2020).
If surgical repair is deemed unsuitable, the reasoning for
this must be clearly and sensitively explained to the
patient based on their individual circumstances,
alongside alternative management options (NICE 2020).
For example, where the AAA is too small to warrant
surgery, patients should be informed that elective repair
of small or medium aneurysms would offer no long-term
survival benefits (Powell et al 2007). Where the patient's
physical condition and comorbidities contraindicate
surgery, it should be explained that elective repair poses
more risks than benefits for people with poor overall
health (NICE 2020).
In comparison, rAAAs are a true surgical emergency and
require urgent surgical treatment (Chaikof et al 2018).
Patients must be assessed on an individual basis for
surgical eligibility and those deemed unlikely to survive
may require palliative management instead. Both the
NICE and ESVS guidelines emphasise that neither a risk
assessment tool nor a single symptom, sign or risk
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factor should be used to determine suitability for surgery
(NICE 2020, Wanhainen et al 2019). This difficult
decision must therefore be made based on clinical
judgment and expertise.
Preoperative management
Before elective AAA repair, management concentrates
on reducing the risk of rupture (NICE 2020). This
involves providing all patients with information, support
and interventions for secondary prevention of CVD,
including nutritional, exercise and weight-loss advice,
diabetes management and anti-platelet therapy (NICE
2020, Wanhainen et al 2019). Patients should be
reassured that moderate physical activity is well
tolerated and does not precipitate aneurysm growth or
rupture (Myers et al 2014). Optimisation may also
include blood pressure control and the management of
hypercholesterolaemia with statins, which has been
shown to improve five-year survival rates in patients with
an AAA (Bahia et al 2016, Sweeting et al 2012).
The most impactful intervention is smoking cessation
and patients should be referred to a 'stop smoking
service' where appropriate (Chaikof et al 2018, NICE
2020). Smoking cessation also improves operative
outcomes, with 8 weeks cessation resulting in a
significantly lower likelihood of pulmonary
complications, compared to shorter term or a lack of
cessation (Arinze et al 2019). Recently, research in
animal models has also identified smoking alternatives,
namely Electronic Cigarette vapour, as a risk factor for
AAA development (Mulorz et al 2019).
Preoperative optimisation of the patient's medications is
also recommended, in accordance with NICE guidelines
(NICE 2020). Beta-blockers should be continued
throughout the perioperative period but should not be
started directly before the surgery, whereas angiotensin-
converting enzyme inhibitors should be stopped on the
morning of surgery and restarted once euvolaemia is
achieved (Chaikof et al 2018). There are currently no
pharmacological interventions recommended to prevent
AAA growth or rupture (NICE 2020). The European
Society for Vascular Surgery has noted that while several
classes of drugs have been investigated in randomised
trials for their ability to reduce the rate of AAA growth,
none have been shown to be effective (Wanhainen et al
2019). However, a clear precipitating cause of a
symptomatic AAA, such as an infection, should be
treated accordingly, as infection increases rupture risk
(Kim 2010). Regardless of the cause, the SVS guidelines
recommend antibiotic prophylaxis within 30 min of
surgery in the form of an intravenous first-generation
cephalosporin or, if penicillin allergic, vancomycin
(Chaikof et al 2018).
RAAAs require an urgent ABCDE assessment,
stabilisation, analgesia, investigations and preparation
for surgery. The regional vascular service should be
notified of the rAAA and the required units of cross-
matched blood ordered from the blood bank, in
accordance with the facilities maximum surgical blood
order schedule. The patient should be transferred to a
regional vascular service within 30 minutes of the
decision to transfer with a restrictive approach to volume
resuscitation utilised (NICE 2020).
Conclusion
AAAs are associated with significant morbidity and
mortality. At-risk groups should therefore undergo
routine screening and upon diagnosis, receive lifestyle
counselling, psychological support and regular
monitoring. It is also important to be aware of how
symptomatic and rAAAs present, are investigated and
are managed in the preoperative period. Depending on
the size and/or rupture status of the AAA, patients may
then progress to definitive surgical repair.
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1. There are many modifiable and non-modifiable risk
factors for AAA development.
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